Sep 29, 2026
MOSANNA THERAPEUTICS REPORTS POSITIVE RESULTS FROM THE PHASE 1 MOSAIC STUDY OF MOS118 FOR OBSTRUCTIVE SLEEP APNEA
Read More
Sep 23, 2026
Broadview Ventures Announces Promotion of Benjamin Kreitman to Associate Director
Download PDF
Aug 25, 2026
Basking Biosciences Announces Positive Topline Phase 1 Data for BB-025, the Reversal Agent for its Acute Ischemic Stroke Thrombolytic Therapy BB-031
Read More
Jul 28, 2026
Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687
Read More
Jul 28, 2026
HAYA Therapeutics Receives FDA Fast Track Designation for HTX-001
Read More
Jul 16, 2026
RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology
Read More
1234